Discover 3,059 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement
for
Stroke, Hypertension, Home Blood Pressure Monitoring,
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 35+
Code: NCT07091851
Recruiting
Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (SLL)
Location: Boston MA, New York NY
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06849713
Phase 2, Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
for
Malignant Neoplasm
Location: Boston MA, Valhalla NY, New York NY, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07630974
Phase 1, Phase 2, Recruiting
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Boston MA, Pittsburgh PA, Houston TX, Los Angeles CA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05019716
Phase 1, Phase 2, Recruiting
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
for
Lymphoma
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT07014293
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
for
Desmoplastic Small Round Cell Tumor, Osteosarcoma,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12 - 39
Code: NCT04616560
Phase 2, Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for
Oligometastatic Prostate Cancer (OMPC)
Location: Boston MA, The Bronx NY, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT05939414
Phase 3, Recruiting
Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease
for
Dry Eye Disease (DED)
Location: Andover MA
Sponsor: Andover Research Eye Institute
Sex: All
Age: 18+
Code: NCT07676084
Recruiting
Re-Engineered Discharge for Diabetes Care Transitions
for
Diabetes Mellitus Type 2, Social Determinants of Health (SDOH),
Location: Worcester MA
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 18+
Code: NCT06869057
Recruiting
Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT06795412
Phase 1, Phase 2, Recruiting
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
for
Basal Ganglia Intracerebral Hemorrhage
Location: Burlington MA, New Haven CT, New York NY,
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18 - 70+
Code: NCT07260916
Recruiting
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)
for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.
Sex: All
Age: 18+
Code: NCT02675946
Phase 1, Recruiting
Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma
for
Multiple Myeloma
Location: Boston MA, Durham NC, Chapel Hill NC, Cincinnati OH,
Sponsor: Prolexys Pharmaceuticals
Sex: All
Age: 18+
Code: NCT01695590
Phase 1, Phase 2, Recruiting
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
for
Cancer Risk, Cancer Predisposition Syndrome,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 0+
Code: NCT05463796
Recruiting
Improving Spatial Perception and Speech Understanding in Multitalker Mixtures
for
Hearing Loss
Location: Boston MA
Sponsor: Boston University Charles River Campus
Sex: All
Age: 18 - 70+
Code: NCT05260307
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)